Ocata Therapeutics Inc fka OCAT

[elllk]

Some other companies are having problems with tumor production from their stem cell derivatives. One thing that is amazing (in addition to beneficial outcomes), and not fully appreciated, is the total lack of problems with Ocata cells. This lack of problems is quite unusual in a breakthrough therapy like this. Of course, when serious problems of other stem cell companies get reported investors who aren't aware of the high quality of Ocata cells get worried about all stem cell companies. Ocata takes an undeserved hit because of that.